Literature DB >> 33779166

Reliable and Accurate Solution to the Induced Fit Docking Problem for Protein-Ligand Binding.

Edward B Miller1, Robert B Murphy2, Daniel Sindhikara1, Kenneth W Borrelli1, Matthew J Grisewood1, Fabio Ranalli1, Steven L Dixon1, Steven Jerome2, Nicholas A Boyles3, Tyler Day1, Phani Ghanakota1, Sayan Mondal1, Salma B Rafi3, Dawn M Troast4, Robert Abel1, Richard A Friesner5.   

Abstract

We present a reliable and accurate solution to the induced fit docking problem for protein-ligand binding by combining ligand-based pharmacophore docking, rigid receptor docking, and protein structure prediction with explicit solvent molecular dynamics simulations. This novel methodology in detailed retrospective and prospective testing succeeded to determine protein-ligand binding modes with a root-mean-square deviation within 2.5 Å in over 90% of cross-docking cases. We further demonstrate these predicted ligand-receptor structures were sufficiently accurate to prospectively enable predictive structure-based drug discovery for challenging targets, substantially expanding the domain of applicability for such methods.

Year:  2021        PMID: 33779166     DOI: 10.1021/acs.jctc.1c00136

Source DB:  PubMed          Journal:  J Chem Theory Comput        ISSN: 1549-9618            Impact factor:   6.006


  11 in total

1.  Contemporary Computational Applications and Tools in Drug Discovery.

Authors:  Philip B Cox; Rishi Gupta
Journal:  ACS Med Chem Lett       Date:  2022-06-01       Impact factor: 4.632

2.  Flexible CDOCKER: Hybrid Searching Algorithm and Scoring Function with Side Chain Conformational Entropy.

Authors:  Yujin Wu; Charles L Brooks
Journal:  J Chem Inf Model       Date:  2021-10-27       Impact factor: 6.162

3.  N-Aryl iminochromenes inhibit cyclooxygenase enzymes via π-π stacking interactions and present a novel class of anti-inflammatory drugs.

Authors:  Ha Thi Nguyen; Thien-Y Vu; A Vijay Kumar; Vo Nguyen Huy Hoang; Pham Thi Ngoc My; Prashant S Mandal; Vinay Bharadwaj Tatipamula
Journal:  RSC Adv       Date:  2021-09-02       Impact factor: 4.036

4.  Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists.

Authors:  Dehui Zhang; David A Perrey; Ann M Decker; Tiffany L Langston; Vijayakumar Mavanji; Danni L Harris; Catherine M Kotz; Yanan Zhang
Journal:  J Med Chem       Date:  2021-06-08       Impact factor: 7.446

5.  Perspectives on High-Throughput Ligand/Protein Docking With Martini MD Simulations.

Authors:  Paulo C T Souza; Vittorio Limongelli; Sangwook Wu; Siewert J Marrink; Luca Monticelli
Journal:  Front Mol Biosci       Date:  2021-03-29

6.  Evaluating Molecular Docking Software for Small Molecule Binding to G-Quadruplex DNA.

Authors:  Jonathan Dickerhoff; Kassandra R Warnecke; Kaibo Wang; Nanjie Deng; Danzhou Yang
Journal:  Int J Mol Sci       Date:  2021-10-06       Impact factor: 5.923

7.  AtomNet PoseRanker: Enriching Ligand Pose Quality for Dynamic Proteins in Virtual High-Throughput Screens.

Authors:  Kate A Stafford; Brandon M Anderson; Jon Sorenson; Henry van den Bedem
Journal:  J Chem Inf Model       Date:  2022-03-02       Impact factor: 4.956

8.  Computational Insights and In Vitro Validation of Antibacterial Potential of Shikimate Pathway-Derived Phenolic Acids as NorA Efflux Pump Inhibitors.

Authors:  Karishma Singh; Roger M Coopoosamy; Njabulo J Gumede; Saheed Sabiu
Journal:  Molecules       Date:  2022-04-18       Impact factor: 4.927

9.  Influenza A virus polymerase acidic protein E23G/K substitutions weaken key baloxavir drug-binding contacts with minimal impact on replication and transmission.

Authors:  Jeremy C Jones; Bogdan Zagribelnyy; Philippe Noriel Q Pascua; Dmitry S Bezrukov; Subrata Barman; Faten Okda; Richard J Webby; Yan A Ivanenkov; Elena A Govorkova
Journal:  PLoS Pathog       Date:  2022-07-13       Impact factor: 7.464

10.  Molecular docking and dynamics based approach for the identification of kinase inhibitors targeting PI3Kα against non-small cell lung cancer: a computational study.

Authors:  Debojyoti Halder; Subham Das; Aiswarya R; Jeyaprakash R S
Journal:  RSC Adv       Date:  2022-08-03       Impact factor: 4.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.